Versant Capital Management, Inc Theravance Biopharma, Inc. Transaction History

Versant Capital Management, Inc

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Jul 22, 2021	SELL	$14.52 - $22.46 $3,470 - $5,367	-239 Closed	0 $0
Q1 2020 Apr 17, 2020	SELL	$17.84 - $31.21 $231 - $405	-13 Reduced 5.16%	239 $5,000
Q4 2019 Jan 28, 2020	SELL	$16.12 - $25.89 $902 - $1,449	-56 Reduced 18.18%	252 $6,000
Q3 2019 Oct 18, 2019	BUY	$16.51 - $23.78 $5,085 - $7,324	308 New	308 $5,000
Q2 2019 Jul 16, 2019	SELL	$15.6 - $25.15 $156 - $251	-10 Closed	0 $0
Q1 2019 Apr 23, 2019	BUY	$22.57 - $28.15 $225 - $281	10 New	10 $0
Q1 2019 Apr 23, 2019	BUY	$22.57 - $28.15 $0 - $0	0 New	0 $0

122

47.3M

200

12.8K

Ticker TBPH
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 66,782,400
Market Cap $640M
Description
Theravance Biopharma, Inc., a biopharmaceutical company, discovers, develops, and commercializes respiratory medicines in the United States, Europe, and Asia. The company offers YUPELRI, a once-daily, nebulized long-acting muscarinic antagonist used for the treatment of chronic obstructive pulmonary disease (COPD). Its product portfolio also inc...

Get notified when there are updates to the investment portfolio of Versant Capital Management, Inc, based on Form 13F filings with the SEC.

Stay updated on Versant Capital Management, Inc with notifications on news.